Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

Autor: Komrokji, Rami S ^*, Lanino, Luca ^*, Ball, Somedeb ^*, Bewersdorf, Jan P ^*, Marchetti, Monia, Maggioni, Giulia, Travaglino, Erica, Al Ali, Najla H, Fenaux, Pierre, Platzbecker, Uwe, Santini, Valeria, Diez-Campelo, Maria, Singh, Avani, Jain, Akriti G, Aguirre, Luis E, Tinsley-Vance, Sarah M, Schwabkey, Zaker I, Chan, Onyee, Xie, Zhouer, Brunner, Andrew M, Kuykendall, Andrew T, Bennett, John M, Buckstein, Rena, Bejar, Rafael, Carraway, Hetty E, DeZern, Amy E, Griffiths, Elizabeth A, Halene, Stephanie, Hasserjian, Robert P, Lancet, Jeffrey, List, Alan F, Loghavi, Sanam, Odenike, Olatoyosi, Padron, Eric, Patnaik, Mrinal M, Roboz, Gail J, Stahl, Maximilian, Sekeres, Mikkael A, Steensma, David P, Savona, Michael R, Taylor, Justin, Xu, Mina L, Sweet, Kendra, Sallman, David A, Nimer, Stephen D, Hourigan, Christopher S, Wei, Andrew H, Sauta, Elisabetta, D’Amico, Saverio, Asti, Gianluca, Castellani, Gastone, Delleani, Mattia, Campagna, Alessia, Borate, Uma M, Sanz, Guillermo, Efficace, Fabio, Gore, Steven D, Kim, Tae Kon, Daver, Navel, Garcia-Manero, Guillermo, Rozman, Maria, Orfao, Alberto, Wang, Sa A, Foucar, M Kathryn, Germing, Ulrich, Haferlach, Torsten, Scheinberg, Phillip, Miyazaki, Yasushi, Iastrebner, Marcelo, Kulasekararaj, Austin, Cluzeau, Thomas, Kordasti, Shahram, van de Loosdrecht, Arjan A, Ades, Lionel, Zeidan, Amer M, Della Porta, Matteo G ^*

Publikováno v: In The Lancet Haematology November 2024 11(11):e862-e872

MYC overexpression is associated with an early disease progression from MDS to AML

Autor: Gajzer, David, Logothetis, Constantine N., Sallman, David A., Calon, Gregoire, Babu, Abida, Chan, Onyee, Vincelette, Nicole D., Volpe, Virginia O., Al Ali, Najla H., Basra, Pukhraz, Talati, Chetasi, Kuykendall, Andrew T., Mo, Qianxing, Padron, Eric, Sweet, Kendra, Komrokji, Rami S., Lancet, Jeffrey E., Yun, Seongseok ^*, Zhang, Ling ^**

Publikováno v: In Leukemia Research December 2021 111

TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

Autor: Sallman, David A. ^{*, *}, McLemore, Amy F. ^*, Aldrich, Amy L., Komrokji, Rami S., McGraw, Kathy L., Dhawan, Abhishek, Geyer, Susan, Hou, Hsin-An, Eksioglu, Erika A., Sullivan, Amy, Warren, Sarah, MacBeth, Kyle J., Meggendorfer, Manja, Haferlach, Torsten, Boettcher, Steffen, Ebert, Benjamin L., Al Ali, Najla H., Lancet, Jeffrey E., Cleveland, John L., Padron, Eric, List, Alan F.

Publikováno v: In Blood 10 December 2020 136(24):2812-2823

SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes

Autor: Zhang, Qing, Haider, Mintallah, Al Ali, Najla H., Lancet, Jeffrey E., Epling-Burnette, Pearlie K., List, Alan F., Padron, Eric, Komrokji, Rami S.

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia June 2020 20(6):400-406

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.